Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.

Area of Science:

• Transplantation immunology
• Cardiovascular research
• Toxicology

Background:

• Tobacco exposure is a risk factor for cardiac allograft vasculopathy and graft loss.
• Direct evidence linking tobacco smoke to early post-transplant outcomes is limited.
• This study investigates the impact of tobacco smoke on cardiac transplant donors and recipients.

Purpose of the Study:

• To determine the effects of pre-transplantation tobacco smoke exposure on cardiac allograft outcomes.
• To investigate the role of inflammatory and alloimmune mediators in tobacco smoke-induced graft injury.
• To establish direct evidence for the detrimental effects of tobacco smoke in cardiac transplantation.

Main Methods:

• Heterotopic rat cardiac transplantation model.
• Exposure of donors and/or recipients to tobacco smoke.
• Analysis of inflammatory (TNF-α, IFN-γ, IL-6) and alloimmune (IL-1R2, PD-1, SDF-1) pathways via PCR and protein expression.
• Histological examination of cardiac allografts.

Main Results:

• Tobacco smoke exposure in donors and/or recipients increased systemic inflammation and oxidative stress.
• Post-transplantation cardiac allograft survival decreased by 33%–57%.
• Intragraft inflammation and alloimmune activation were significantly elevated, leading to myocardial and vascular destruction.

Conclusions:

• Tobacco smoke exposure in either donors or recipients accelerates allograft rejection.
• Vascular inflammation and graft loss are consequences of tobacco smoke exposure.
• Alloimmune activation, driven by tobacco smoke-induced inflammation, is a key mechanism in accelerated rejection.